首页> 外文期刊>Journal of addictive diseases: the official journal of the ASAM, American Society of Addiction Medicine >Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness.
【24h】

Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness.

机译:纳曲酮在伴发重大精神疾病患者的酒精使用障碍的治疗中的使用。

获取原文
获取原文并翻译 | 示例
           

摘要

We report the use of naltrexone for treatment of alcohol use disorder in patients with major psychiatric illness. We reviewed the records of 72 mentally ill outpatients treated with naltrexone for alcohol use disorders at a community mental health center. The psychiatric diagnoses included major depression (n = 37), schizophrenia (n = 17), bipolar illness (n = 11), schizoaffective disorder (n = 7), and gender identity disorder (n = 4). Sixty-one patients (85%) had histories of psychiatric hospitalization. Total retention in naltrexone treatment for at least eight weeks was 81.9%: 5 (6.9%) were lost to follow-up, and 8 (11.1%) discontinued the medication because of side effects, primarily nausea. Patients showed good clinical response to naltrexone, with 82% reducing their drinking by at least 75%, and only 17% relapsing at eight weeks. We conclude that naltrexone is useful in the treatment of dually-disordered patients. The hypothesis that clinical response to naltrexone is facilitated by active alcohol drinking during treatment is discussed.
机译:我们报告了使用纳曲酮治疗重大精神疾病患者的酒精使用障碍。我们在社区精神卫生中心回顾了接受纳曲酮治疗酒精滥用障碍的72名精神疾病门诊患者的记录。精神病学诊断包括严重抑郁症(n = 37),精神分裂症(n = 17),躁郁症(n = 11),精神分裂症(n = 7)和性别认同障碍(n = 4)。六十一名患者(85%)有精神病住院史。纳曲酮治疗的至少8周总保留率为81.9%:5例(6.9%)因随访而丢失,8例(11.1%)由于副作用(主要是恶心)而停药。患者对纳曲酮表现出良好的临床反应,其中有82%的患者减少了至少75%的饮酒,而只有18%的患者在8周时复发。我们得出的结论是,纳曲酮可用于治疗双重疾病的患者。讨论了在治疗期间积极饮酒有助于对纳曲酮的临床反应的假说。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号